| Names | |
|---|---|
| Preferred IUPAC name 5-(Hydroxymethyl)-2,4-dimethylpyridin-3-ol | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C8H11NO2 | |
| Molar mass | 153.181 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
4-Deoxypyridoxine is a vitamin B6 antagonist. [1] It may be toxic to developing embryos since it can have negative effects on collagen and elastin during development. [2] The presence of this compound can produce vitamin B6 deficiency, which suppresses the immune system. [3] 4-Deoxypyridoxine lowers vitamin B6 concentration by competitively inhibiting some of the enzymes necessary for the regeneration of vitamin B6. [4] The related immunosuppression can be beneficial in animal models of Trichinella spiralis infections. [5] 4-Deoxypyridoxine has also been described as an inhibitor of sphingosine-1-phosphate lyase. [6] The inhibition of sphingosine-1-phosphate lyase by 4-deoxypyridoxine has been shown to prevent cell death of ex vivo animal pancreatic islets. The use of 4-deoxypyridoxine to prevent stress-induced apoptosis is suggest that the compound, as well as other inhibitors of sphingosine-1-phosphate lyase, could be used to increase the viability of donor pancreatic tissue in the treatment of diabetes. [7]